[Prostate carcinoma - PSA screening reduces risk of metastasis formation]
- PMID: 23904119
- DOI: 10.1055/s-0033-1351763
[Prostate carcinoma - PSA screening reduces risk of metastasis formation]
Comment on
-
Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).Eur Urol. 2012 Nov;62(5):745-52. doi: 10.1016/j.eururo.2012.05.068. Epub 2012 Jun 7. Eur Urol. 2012. PMID: 22704366 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical